Literature DB >> 11575447

Characterization of virulence factors of mouse-adapted Helicobacter pylori strain SS1 and effects on gastric hydrophobicity.

A S Day1, N L Jones, Z Policova, H A Jennings, E K Yau, P Shannon, A W Neumann, P M Sherman.   

Abstract

Gastric infection with Helicobacter pylori results in chronic active gastritis and in some individuals is associated with complications such as peptic ulceration and gastric cancers. A balance between bacterial factors and host responses may determine disease outcome. The mouse-adapted H. pylori strain SS1 has been utilized as a model to study disease pathogenesis. Although chronic gastritis is observed in this murine model of H. pylori infection, other complications of disease seen in the human host (such as peptic ulceration) are not identified. The objectives of this study were to characterize virulence factors of the mouse-adapted H. pylori strain SS1 and determine host responses to infection. Vacuolating cytotoxin activity of H. pylori strain SS1 was determined after incubation of HEp-2 cells with culture supernatant for 24 hr. Polymerase chain reaction was performed to detect the presence of the cagA and cagE genes. Chemokine responses from human gastric epithelial cells infected with H. pylori SS1 were assessed by measurement of the concentration of interleukin-8 in cell-free supernatants. C57BL/6 and gld mice were infected with strain SS1 or sham-infected. Eight weeks following infection, gastric tissues were obtained for histological analysis and surface hydrophobicity was measured by axisymmetric drop-shape analysis. H. pylori strain SS1 was cytotoxin negative, cagA positive, and cagE positive, but induced only a modest interleukin-8 response (684 +/- 140 pg/ml) from AGS gastric epithelial cells in comparison to a clinical isolate (4170 +/- 410 pg/ml, P < 0.0005). Increased inflammation was observed in the stomachs of H. pylori strain SS1-infected animals compared to uninfected controls. Gastritis was not associated with any disease complications. Despite mucosal inflammation, infected mice did not demonstrate alterations in gastric surface hydrophobicity (42.2 degrees +/- 2.2 degrees and 41.4 degrees +/- 3.2 degrees for C57BL/6 and gld, respectively) compared to uninfected mice (43.2 degrees +/- 2.3 degrees and 39.5 degrees +/- 1.6 degrees, respectively). In conclusion, murine infection with H. pylori SS1, which contains putative bacterial virulence factors, results in gastric inflammation. However, the mucosal changes are not associated with alterations in surface hydrophobicity. Therefore, the mouse model of infection with H. pylori, strain SS1 may not serve as an entirely appropriate model to study host factors associated with disease complications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11575447     DOI: 10.1023/a:1010691216207

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  A rat model of chronic Helicobacter pylori infection. Studies of epithelial cell turnover and gastric ulcer healing.

Authors:  H Li; I Kalies; B Mellgård; H F Helander
Journal:  Scand J Gastroenterol       Date:  1998-04       Impact factor: 2.423

2.  Measurement of the surface hydrophobicity of human gastrointestinal mucosa.

Authors:  R T Spychal; J M Marrero; S H Saverymuttu; T C Northfield
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

3.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

4.  Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States.

Authors:  S Miehlke; K Kibler; J G Kim; N Figura; S M Small; D Y Graham; M F Go
Journal:  Am J Gastroenterol       Date:  1996-07       Impact factor: 10.864

5.  Gastric mucosal hydrophobicity in duodenal ulceration: role of Helicobacter pylori infection density and mucus lipids.

Authors:  M Asante; H Ahmed; P Patel; T Davis; C Finlayson; M Mendall; T Northfield
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

6.  Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro.

Authors:  S E Crowe; L Alvarez; M Dytoc; R H Hunt; M Muller; P Sherman; J Patel; Y Jin; P B Ernst
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

7.  Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently.

Authors:  A Hackelsberger; U Platzer; M Nilius; V Schultze; T Günther; J E Dominguez-Muñoz; P Malfertheiner
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

8.  Gastric mucosal hydrophobicity and Helicobacter pylori: response to antimicrobial therapy.

Authors:  M F Go; G M Lew; L M Lichtenberger; R M Genta; D Y Graham
Journal:  Am J Gastroenterol       Date:  1993-09       Impact factor: 10.864

9.  Long-term storage of Campylobacter pylori.

Authors:  B Drumm; P Sherman
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

10.  Gastric mucosal barrier: evidence for Helicobacter pylori ingesting gastric surfactant and deriving protection from it.

Authors:  B A Hills
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

View more
  8 in total

1.  Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability.

Authors:  Jason P Fedwick; Tamia K Lapointe; Jonathan B Meddings; Philip M Sherman; Andre G Buret
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  A Mouse Model of Helicobacter pylori Infection.

Authors:  Tanmoy Kumar Dey; Bipul Chandra Karmakar; Avijit Sarkar; Sangita Paul; Asish Kumar Mukhopadhyay
Journal:  Methods Mol Biol       Date:  2021

3.  Helicobacter pylori disrupts STAT1-mediated gamma interferon-induced signal transduction in epithelial cells.

Authors:  David J Mitchell; Hien Q Huynh; Peter J M Ceponis; Nicola L Jones; Philip M Sherman
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  The association between cagA+ H. pylori infection and distal gastric cancer: a proposed model.

Authors:  Mohammed S Al-Marhoon; Sheila Nunn; Roger W Soames
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

5.  Helicobacter pylori phagosome maturation in primary human macrophages.

Authors:  Glenn N Borlace; Hilary F Jones; Stacey J Keep; Ross N Butler; Doug A Brooks
Journal:  Gut Pathog       Date:  2011-03-23       Impact factor: 4.181

6.  Quantum changes in Helicobacter pylori gene expression accompany host-adaptation.

Authors:  Eng-Guan Chua; Michael J Wise; Yalda Khosravi; Shih-Wee Seow; Arlaine A Amoyo; Sven Pettersson; Fanny Peters; Chin-Yen Tay; Timothy T Perkins; Mun-Fai Loke; Barry J Marshall; Jamuna Vadivelu
Journal:  DNA Res       Date:  2017-02-01       Impact factor: 4.458

7.  Transcriptional profiling of gastric epithelial cells infected with wild type or arginase-deficient Helicobacter pylori.

Authors:  Songhee H Kim; Rosa A Sierra; David J McGee; Jovanny Zabaleta
Journal:  BMC Microbiol       Date:  2012-08-13       Impact factor: 3.605

8.  Caveolin-1 protects B6129 mice against Helicobacter pylori gastritis.

Authors:  Ivana Hitkova; Gang Yuan; Florian Anderl; Markus Gerhard; Thomas Kirchner; Simone Reu; Christoph Röcken; Claus Schäfer; Roland M Schmid; Roger Vogelmann; Matthias P A Ebert; Elke Burgermeister
Journal:  PLoS Pathog       Date:  2013-04-11       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.